NIH-funded research Fellowship grant

Investigating the role of MICU3 in Alzheimer's disease development

Official title: The Role of MICU3 in Alzheimer's Disease Pathogenesis

Funded at Temple Univ of the Commonwealth · NIH-10974464 · Data updated 2026-11-12

This study is looking at how calcium in our cells affects brain health and could play a role in Alzheimer's disease, especially in older adults, with the hope of finding new ways to help improve treatment options for those experiencing memory and thinking problems.

More s Disease research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionTemple Univ of the Commonwealth
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 1, 2023
Project endJune 30, 2027
Funding year2024
Award (this year)$34,755
NIH project number5F30AG082407-02
Project IDNIH-10974464 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 65 and older who are experiencing symptoms of Alzheimer's disease or are at risk for developing it.

Less likely to help

Patients under the age of 65 or those without any signs of cognitive decline may not receive benefit from this research.

What this research studies

This research focuses on understanding how mitochondrial calcium regulation contributes to the development of Alzheimer's disease (AD). It explores the mechanisms behind mitochondrial calcium overload and its effects on brain health, particularly in older adults. By studying specific genetic factors and their impact on calcium transport in neurons, the research aims to uncover new therapeutic targets for AD. Patients may benefit from insights that could lead to innovative treatments for cognitive decline associated with Alzheimer's.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that improve cognitive function and slow the progression of Alzheimer's disease.

How similar studies have gone: Previous research has shown promise in targeting mitochondrial dysfunction in Alzheimer's models, suggesting that this approach could yield significant insights.

Where this research is happening

  • Temple Univ of the Commonwealth
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Cohen, Henry — Temple Univ of the Commonwealth
  • Study coordinator: Cohen, Henry

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.